Condition
    Moderate Evidence
    Effectiveness 3/5

    Probiotics for Eczema (Atopic Dermatitis)

    Probiotics show the clearest benefit for eczema prevention when given perinatally, with weaker and less consistent effects when used to treat established disease. Strain choice matters and results do not generalise across products.

    Overview

    Probiotics show the clearest benefit for eczema prevention when given perinatally, with weaker and less consistent effects when used to treat established disease. Strain choice matters and results do not generalise across products.

    Verdict

    Mixed evidence

    How It Works

    The gut microbiome shapes immune development, particularly the balance between Th1, Th2 and regulatory T cell responses. Atopic dermatitis is characterised by Th2 dominance, and certain Lactobacillus and Bifidobacterium strains promote regulatory T cell induction and IL-10 production, which is the proposed corrective route. Probiotics also strengthen intestinal barrier function through tight junction protein expression, potentially reducing translocation of antigens that drive systemic allergic sensitisation. Both mechanisms are strain-specific, which is why findings from one organism cannot be assumed to apply to another.

    Dosing & Protocol

    Typical dose

    Recommended dose
    10-50 billion CFU daily with multiple strains
    Expected timeframe
    8-12 weeks

    Protocol

    form
    Capsule, or powder mixed into cool food for children
    duration
    8-12 weeks with a SCORAD or POEM score at baseline and end
    co factor
    Take with food and continue emollients and topical treatment. Evidence is mixed and the distinction matters: maternal and infant probiotics reduce eczema incidence in at-risk infants in several meta-analyses, whereas treatment of established eczema shows much weaker and inconsistent effects.
    titration
    Keep to label dose
    starting dose
    1-10 billion CFU daily of Lactobacillus rhamnosus GG or a mixed Lactobacillus/Bifidobacterium formula

    Evidence

    What the studies say

    Meta-analyses of perinatal probiotic supplementation - given to mothers in late pregnancy and to infants after birth - show a reduction in the incidence of atopic dermatitis in high-risk children, and several allergy guidelines conditionally support this use. Trials treating established eczema report smaller and less consistent improvements in SCORAD, with mixed-strain preparations and Lactobacillus rhamnosus GG among the more studied options. Cochrane reviews of probiotics for treating eczema have concluded that the effect on symptom severity is small and of uncertain clinical importance. Because outcomes vary by strain, dose and timing, results from one product should not be assumed to transfer to another.

    Probiotics for treating eczema

    Score: 10/10
    2018
    systematic_review
    n=2599

    Makrgeorgou A, Leonardi-Bee J, Bath-Hextall FJ +4 more

    Current evidence indicates that probiotics probably make little or no difference in improving patient-rated eczema symptoms.

    View source

    Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

    Score: 7/10
    2001
    rct
    n=159

    Kalliomaki M, Salminen S, Arvilommi H

    Perinatal LGG halved the frequency of atopic eczema in at-risk children at age two (23% vs 46%).

    View source

    Safety

    Caveats

    Probiotics are adjunctive - do not reduce emollients or topical corticosteroids, and weeping or crusted eczema may be infected and needs medical treatment. Do not use live probiotics in severe immunosuppression, premature infants outside specialist care, with central venous catheters, or in critical illness. Milk-protein-containing products can be a problem in cow milk allergy, which often coexists with atopic eczema - check the excipients. Generally acceptable in pregnancy, and prenatal use is what the prevention data support; confirm with a clinician.

    Less likely to help if

    Children and adults with established moderate to severe eczema, where treatment trials were largely negative.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.